|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
| 408 | Wed, 8/6/08, 12:30 PM - 1:50 PM | HY-Capitol Ballroom 4 |
| Biopharmaceutical Section Roundtables with Lunch (fee event) - Roundtables - with Lunch | ||
|
Biopharmaceutical Section |
||
| Organizer(s): Matilde Sanchez, Arena Pharmaceuticals | ||
| WL10: |
A Bayesian Approach to the ICH Q8 Definition of Design Space —  John J. Peterson, GlaxoSmithKline Pharmaceuticals
|
|
| WL11: |
Do Statisticians Still Look at the Data? — Bret J. Musser, Merck Research Laboratories
|
|
| WL12: | CANCELLED - Prespecifying Analyses: In the Lifecycle of a Clinical Trial, Does It Matter When, Where, and How You Prespecify? — Bruce Binkowitz, Merck Research Laboratories | |
| WL13: |
Patient-Reported Outcomes: Measurement Reliability and Sensitivity — Tammy Massie, U.S. Food and Drug Administration
|
|
| WL14: |
Applying Lean Six Sigma Concepts to Adaptive Trial Logistics — Darcy Hille, Merck & Co., Inc.; Paulette Ceesay, Merck & Co., Inc.
|
|
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |